New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

BMEDvsVHTETF Comparison

ETF 1
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-1.76%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
-0.99%

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. Vanguard Health Care ETF (VHT) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.09% for VHT. BMED is up 14.51% year-to-date (YTD) with +$5M in YTD flows. VHT performs better with 14.81% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of BMED and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BMED vs VHT performance and flow charts

Performance

-1.00.01.02.03.04.05.0%Sep 16Sep 23Sep 30Oct 7Oct 14

Cumulative Flows

-60 M-40 M-20 M0 M20 M40 MSep 16Sep 23Sep 30Oct 7Oct 14

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/16/2026
1M3MYTD1Y3Y5Y
Perf.
BMED
VHT
+3.05%+4.26%
+12.16%+7.84%
+14.51%+14.81%
+24.44%+24.81%
+54.98%+43.83%
+20.00%+42.78%
Flows
BMED
VHT
--$69M
+$1M+$135M
+$5M-$3M
+$6M+$157M
+$7M-$2.17B
+$6M-$1.08B
Volatility and drawdown
3M1Y3Y5Y
Volatility
BMED
VHT
+21.82%+16.36%
+17.81%+15.64%
+16.86%+14.81%
+18.13%+15.60%
Max drawdown
BMED
VHT
-5.85%-5.63%
-14.71%-10.39%
-19.76%-16.88%
-32.14%-17.77%
Max drawdown duration
BMED
VHT
31d56d
196d169d
237d435d
1479d767d
Trading data

Create an account to view trading data

Join for free
BMED
VHT
Last sale
10/16/2026 at 6:23 PM
$34.55
$326.66
Previous close
10/16/2026
$35.06
$327.15
Consolidated volume
10/16/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BMED
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/16/2026 at 6:23 PM
Live
Closed
BMED
VHT
Last price
$34.55
$326.66
1D performance
-1.45%
-0.15%
AuM$13.83 M$19.67 B
E/R0.77%0.09%
Characteristics
BMED
VHT
Management strategyActivePassive
ProvideriSharesVanguard
Benchmark-MSCI US IMI Health Care 25/50 Index
N° of holdings53412
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 29, 2020January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

BMED
USA
87.23%
Other
12.77%
VHT
USA
96.81%
Other
3.19%

Sectors

BMED
Healthcare
98.95%
Other
1.05%
VHT
Healthcare
97.74%
Other
2.26%
Advertisement

Diversification

BMED

Total weight of top 15 holdings out of 15

58.7%
VHT

Total weight of top 15 holdings out of 15

60.65%

Top 15 holdings

Data as of August 31, 2026
BMED
Gilead Sciences, Inc.
5.01%
Merck & Co., Inc.
4.99%
AbbVie, Inc.
4.61%
Johnson & Johnson
4.27%
Charles River Laboratories International, Inc.
4.22%
Thermo Fisher Scientific, Inc.
4.12%
Edwards Lifesciences Corp.
3.95%
Moderna, Inc.
3.86%
IQVIA Holdings, Inc.
3.72%
Danaher Corp.
3.64%
Vertex Pharmaceuticals, Inc.
3.56%
Waters Corp.
3.53%
Biogen, Inc.
3.45%
Mettler-Toledo International, Inc.
3.16%
DexCom, Inc.
2.61%
VHT
Eli Lilly & Co.
12.79%
Johnson & Johnson
8.72%
AbbVie, Inc.
6.26%
Merck & Co., Inc.
5.04%
UnitedHealth Group, Inc.
4.89%
Amgen, Inc.
3.21%
Thermo Fisher Scientific, Inc.
3.17%
Abbott Laboratories
2.66%
Gilead Sciences, Inc.
2.51%
Pfizer Inc.
2.24%
Vertex Pharmaceuticals, Inc.
1.91%
Bristol Myers Squibb Co.
1.88%
Danaher Corp.
1.88%
Intuitive Surgical, Inc.
1.84%
CVS Health Corp.
1.66%
Frequently asked questions about BMED and VHT

How have the BMED and VHT ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while VHT has returned 14.81%. That puts VHT better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or VHT?

Year-to-date, the BMED ETF saw +$5M in flows, compared to -$3M for VHT.

Which ETF is more volatile: BMED or VHT?

Over the past year, BMED had a volatility of 17.81%, while VHT experienced 15.64%.

Which ETF is bigger: BMED or VHT?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while VHT manages $19.67 B.

What sectors do the BMED and VHT ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the BMED ETF and VHT ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: BMED or VHT?

BMED holds 55 securities with 58.7% of its assets in the top 15. VHT has 412 securities and a top 15 weight of 60.65%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.

Global ETF Survey 2026